Insider Trading & Ownership - Versant Voyageurs I L.P.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Versant Voyageurs I L.P.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-08-28
Sale
2024-08-30
4:16 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I L.P.
Versant Voyageurs I Parallel L.P.
Versant Vantage I L.P.
10% Owner
221,600 $6.3202 $1,400,556 6,206,964
(Indirect
Direct)
View
2022-01-03
Sale
2022-01-05
5:16 pm
CHINOOK THERAPEUTICS INC. KDNY Versant Venture Capital VII L.P.
Versant Voyageurs I L.P.
Versant Voyageurs I Parallel L.P.
10% Owner
1,000,000 $16 $16,000,200 4,175,172
(Indirect
Direct)
View
2021-08-27
Sale
2021-08-31
7:06 pm
CHINOOK THERAPEUTICS INC. KDNY Versant Venture Capital VII L.P.
Versant Voyageurs I L.P.
Versant Voyageurs I Parallel L.P.
10% Owner
850,000 $14 $11,900,000 4,867,172
(Indirect
Direct)
View
2020-11-30
Sale
2020-12-01
7:13 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
10,393 $33.15 $344,513 6,062,813
(Indirect
Direct)
View
2020-11-19
Sale
2020-11-23
4:41 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
130,017 $33.01 $4,291,861 7,646,829
(Indirect
Direct)
View
2020-11-17
Sale
2020-11-19
9:19 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
4,730 $33.05 $156,349 7,776,846
(Indirect
Direct)
View
2020-11-13
Sale
2020-11-17
7:33 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
4,700 $33.74 $158,587 7,781,576
(Indirect
Direct)
View
2020-11-12
Sale
2020-11-13
7:47 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
15,598 $34.15 $532,642 6,937,033
(Indirect
Direct)
View
2020-11-10
Sale
2020-11-12
5:41 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
39,583 $34.11 $1,350,354 8,751,874
(Indirect
Direct)
View
2020-11-06
Sale
2020-11-10
7:24 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
9,400 $33.08 $310,949 8,791,457
(Indirect
Direct)
View
2020-11-04
Sale
2020-11-06
4:44 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
11,348 $33.14 $376,127 8,800,857
(Indirect
Direct)
View
2020-10-26
Sale
2020-10-28
5:58 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
8,903 $33.28 $296,293 8,812,205
(Indirect
Direct)
View
2020-10-15
Sale
2020-10-20
8:09 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
15,746 $33.44 $526,529 8,821,108
(Indirect
Direct)
View
2020-10-13
Sale
2020-10-15
7:22 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
17,240 $33.3 $574,015 8,836,854
(Indirect
Direct)
View
2020-10-08
Sale
2020-10-13
7:41 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
22,625 $33.5 $757,924 8,854,094
(Indirect
Direct)
View
2020-10-06
Sale
2020-10-08
7:14 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
45,926 $33.44 $1,535,732 6,056,892
(Indirect
Direct)
View
2020-08-10
Sale
2020-08-12
7:57 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
13,792 $33.06 $455,989 10,541,469
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-04-04
Other
2022-04-06
4:38 pm
N/A
N/A
CHINOOK THERAPEUTICS INC. KDNY Versant Venture Capital VII L.P.
Versant Voyageurs I L.P.
Versant Voyageurs I Parallel L.P.
10% Owner
735,873 $0 6,090,209
(Direct)
View
2020-12-14
Other
2020-12-16
7:04 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
21,401 $0 5,628,442
(Indirect)
View
2020-11-27
Other
2020-12-01
7:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
440,782 $0 6,062,813
(Direct)
View
2020-11-23
Other
2020-11-25
4:49 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
788,828 $0 5,151,052
(Direct)
View
2020-11-11
Other
2020-11-13
7:47 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
984,298 $0 6,937,033
(Direct)
View
2020-10-07
Other
2020-10-08
7:14 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
299,051 $0 6,056,892
(Indirect)
View

Ownership
2020-10-07
8:25 pm
N/A
N/A
ADURO BIOTECH INC. KDNY Versant Venture Capital VII L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
10% Owner
0 $0 7,888,369
(Indirect)
View
2020-09-17
Other
2020-09-21
7:28 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
754,743 $0 6,569,238
(Direct)
View
2020-08-18
Other
2020-08-20
6:13 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
311,176 $0 10,263,821
(Direct)
View
2020-08-12
Other
2020-08-14
5:55 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
311,176 $0 10,563,821
(Direct)
View
2020-07-27
Other
2020-07-29
9:56 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
339,843 $0 7,151,621
(Indirect)
View